Over 27 years of experience in the creation of ultrasound devices for Rehabilitation,Physiotherapy, Sports Medicine and Aesthetic Medicine, gives Fisioline® a significant advantage in designing an innovative equipment for O.P.A.F.® Therapy(High-frequency pressure waves).

O.P.A.F.® Therapy is a new device which produces high-frequency pressure waves exploiting an innovative output stage called Class E.

The high peak power of the generated waves allows to obtain an amplified mechanical effect with a greater energy to break up, for a high power focalized action in depth.

O.P.A.F.® Therapy uses a new self-regulation system related to the impedance of the treated tissue, which enables the constant transmission of the transferred power.The elevated mechanical efficiency consequently obtained translates into a greattherapeutic efficiency.

O.P.A.F.® Therapy can be used both as an ultrasound in Class E and a disrupting wave.The versatility of O.P.A.F.® Therapy offers the operator the possibility to work on severalpathologies: calcifications, muscular lesions, tendonitis, epicondylitis, plantar fasciitis,shoulder calcific tendinopathy, articular rigidity, calcaneal spur.

O.P.A.F.® Therapy measures the patient’s tissue impedance and, together with the Energy Power Bar, monitors and real-time displays the energy transferred to the tissues.The device is also equipped with a protection system that detects the contact of the applicator on the skin, for safe and problem-free procedures.

O.P.A.F.® Therapy is a compact instrument, light and easily transportable, that offers extraordinary performances able to satisfy every demand of treatment.

technical features
• N° 1 applicator for O.P.A.F.® Therapy 1-3MHz with a diameter of 55mm(contact surface 24 cm2)
• N° 1 Carrying case
• N° 1 Gel bottle

standard accessories reference standard
• EN EN 60601-1, (IEC 60601-1)
• EN 60601-2-5, (IEC 60601-2-5)
• EN 60601-1-2 (IEC 60601-1-2)
• EN 60601-1-4 (IEC 60601-1-4)
• EN 61689 (IEC 1689)

Marking: the device complies with the requirements specified in the Directive 93/42/EEC,
modified by the Directive 2007/47/EC, and in the Directive 2004/108/EC.

source:Fisiolife